Medpace
MEDP
268 hedge funds and large institutions have $2.42B invested in Medpace in 2019 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 84 increasing their positions, 89 reducing their positions, and 18 closing their positions.
239% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 18
23% more capital invested
Capital invested by funds: $1.97B → $2.42B (+$450M)
19% more funds holding
Funds holding: 225 → 268 (+43)
16% more call options, than puts
Call options by funds: $8M | Put options by funds: $6.91M
6% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 89
3.96% less ownership
Funds ownership: 84.84% → 80.88% (-4%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$22.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$10.5M |
| 4 |
Renaissance Technologies
New York
|
+$9.89M |
| 5 |
Goldman Sachs
New York
|
+$9.6M |
Top Sellers
| 1 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
-$47.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$45.3M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$31.2M |
| 4 |
PG
Pendal Group
Sydney,
Australia
|
-$21.1M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$18.5M |
MEDP Hedge Fund Activity: Q3 2019 in Review
268 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2019, worth a combined $2.42B — up 23% from $1.97B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new MEDP positions and 18 closed out — a net gain of 43 holders — while 84 added to existing stakes and 89 trimmed.
The largest buyer was Nuveen, adding an estimated $22.7M. The largest seller was Blue Harbour Group, exiting entirely with an estimated $47.5M sold.
- 268 institutional investors held Medpace (MEDP) as of Q3 2019, up from 225 in Q2 2019.
- Funds reported $2.42B of Medpace stock for Q3 2019, up 23% quarter-over-quarter.
- 61 funds opened new Medpace positions in Q3 2019 and 18 closed out, a net change of +43 holders.
- The largest Medpace buyer in Q3 2019 was Nuveen, an estimated $22.7M added.
- The largest Medpace seller in Q3 2019 was Blue Harbour Group, an estimated $47.5M sold.
Based on aggregated 13F filings for Q3 2019.